Since mutations in SDHB gene are the most frequent cause of metastatic paraganglioma tumors, it has consistently been proposed that all patients presenting with malignant paraganglioma/pheochromocytoma should be tested for SDHB gene mutations. This evidence concerns the gene SDHB and hereditary pheochromocytoma-paraganglioma.